Quality of non-steroid anti-inflammatory drugs (NSAIDs) utilization in primary care in Rijeka;Kvaliteta propisivanja nesteroidnih antireumatika (NSAR) u općoj praksi u Rijeci

Medicina

Volumn 38, Issue 3-4, 2002, Pages 66-68

  Vlabović Palčevski, Vera ^a  

^a KBC RIJEKA   (Croatia)

Author keywords

Non steroid anti inflammatory; Primary eare; Utilization

Indexed keywords

DICLOFENAC; IBUPROFEN; INDOMETACIN; KETOPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; TENOXICAM;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG UTILIZATION; DYSPEPSIA; EVIDENCE BASED MEDICINE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL TOXICITY; HUMAN; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; RISK BENEFIT ANALYSIS;

EID: 1442281772     PISSN: 00257729     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Singh G, Triadafilopoulos G (1999) Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol 26 (Suppl 56): 18-24
2. Brooks PM. Rheumatic disorders. In: Speight TM, editor. Avery's drug treatment. 4th ed. Auckland: Adis Press, 1997:1114-1161
3. Wolfe MM, Lichtenstein DR, Singh G (1999) Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med 340:1888-1899
4. Huic M, Macolic V, Vrhovac B, Francetic I, Bakran I, Giljanovic S (1994) Adverse drug reactions resulting in hospital admission. Int J Clin Pharmacol Ther 32(12):675-82
5. Henry D, Lim LL-Y,Garcia Rodrigues LA, Perez Gutthann S, Carson JL, Griffin M, Savage R, Logan R, Moride Y, Hawkey C, Hill S, Fries JT (1996) Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analyses. BMJ 312:1563-1566
6. Hernandez-Diaz S, Garcia Rodriguez LA (2000) Association between non-steroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation. An overview of epidemiologic studies published in the 1990s. Arch Intern Med 160:2093-2099.
7. Rawlins MD (2000) Hospitalization for adverse drug reactions. Abstract 9 of the joint meeting of VII World Conference on Clinical Pharmacology and Therapeutics IUPHAR-Division of Clinical Pharmacology and 4th Congress of the European Association for Clinical pharmacology and Therapeutics (EACPT) CPT 2000, Florence 15-20 July. Br J Clin Pharmacol pp.4
8. McGavock H. Handbook of Drug Use Research Methodology. the United Kingdom Drug Utilization Research Group, 1st ed. 2000
9. Bergman U, Andersen M, Vaccheri A, Bjerrum L, Wettermark B, Montanaro N (2000) Deviations from evidence-based prescribing of non-steroidal anti-inflammatory drugs in three European regions. Eur J Clin Pharmacol 56:269-272
10. WHO collaborating Centre for Drug Statistics methodology (2000). ATC Index with DDD's. Oslo, WHO 2000
11. V. Vlahović-Palčevski, B. Wettermark, U.Bergman. Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm). Eur J Clin Pharmacol 2002; 58:209-214